{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T12:12:27Z","timestamp":1754482347842,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10875-020-00809-3","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:02:32Z","timestamp":1593043352000},"page":"780-782","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Successful Artery Embolization in a Patient with Autoimmune Lymphoproliferative Syndrome Associated with Splenic Rupture"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6691-5439","authenticated-orcid":false,"given":"Kensaku","family":"Kohrogi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Migita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Anan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sugahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kanegane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimitoshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,25]]},"reference":[{"issue":"14","key":"809_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1182\/blood-2010-04-280347","volume":"116","author":"JB Oliveira","year":"2010","unstructured":"Oliveira JB, Bleesing JJ, Dianzani U, Fleisher TA, Jaffe ES, Lenardo MJ, et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood. 2010;116(14):35\u201340. https:\/\/doi.org\/10.1182\/blood-2010-04-280347.","journal-title":"Blood."},{"issue":"1","key":"809_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1182\/blood-2015-07-657981","volume":"127","author":"KL Bride","year":"2016","unstructured":"Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, et al. Sirolimus is effective in relapsed\/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood. 2016;127(1):17\u201328. https:\/\/doi.org\/10.1182\/blood-2015-07-657981.","journal-title":"Blood."},{"issue":"18","key":"809_CR3","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","volume":"118","author":"B Neven","year":"2011","unstructured":"Neven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, de Somer L, et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood. 2011;118(18):4798\u2013807. https:\/\/doi.org\/10.1182\/blood-2011-04-347641.","journal-title":"Blood."},{"key":"809_CR4","doi-asserted-by":"publisher","unstructured":"Aubrey-Bassler FK, Sowers N. 613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review. BMC Emerg Med. 2012;12. https:\/\/doi.org\/10.1186\/1471-227X-12-11.","DOI":"10.1186\/1471-227X-12-11"},{"issue":"4","key":"809_CR5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jvir.2019.05.031","volume":"31","author":"B Kis","year":"2019","unstructured":"Kis B, Mills M, Smith J, Choi J, Sagatys E, Komrokji R, et al. Partial splenic artery embolization in 35 cancer patients: results of a single institution retrospective study. J Vasc Interv Radiol. 2019;31(4):584\u201391. https:\/\/doi.org\/10.1016\/j.jvir.2019.05.031.","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"809_CR6","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00270-015-1162-8","volume":"38","author":"PT Foley","year":"2015","unstructured":"Foley PT, Kavnoudias H, Cameron PU, Czarnecki C, Paul E, Lyon SM. Proximal versus distal splenic artery embolisation for blunt splenic trauma: what is the impact on splenic immune function? Cardiovasc Intervent Radiol. 2015;38(5):1143\u201351. https:\/\/doi.org\/10.1007\/s00270-015-1162-8.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"9","key":"809_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.cdd.4400426","volume":"5","author":"JP Haas","year":"1998","unstructured":"Haas JP, Grunke M, Frank C, Kolowos W, Dirnecker D, Leipold G, et al. Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas\/apo-1 mutation. Cell Death Differ. 1998;5(9):751\u20137. https:\/\/doi.org\/10.1038\/sj.cdd.4400426.","journal-title":"Cell Death Differ"},{"issue":"5","key":"809_CR8","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/S0301-472X(99)00033-8","volume":"27","author":"AMJ Peters","year":"1999","unstructured":"Peters AMJ, Kohfink B, Martin H, Griesinger F, W\u00f6rmann B, Gahr M, et al. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin\u2019s disease. Exp Hematol. 1999;27(5):868\u201374. https:\/\/doi.org\/10.1016\/S0301-472X(99)00033-8.","journal-title":"Exp Hematol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00809-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-020-00809-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-020-00809-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T23:56:56Z","timestamp":1624579016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-020-00809-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,25]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["809"],"URL":"https:\/\/doi.org\/10.1007\/s10875-020-00809-3","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"type":"print","value":"0271-9142"},{"type":"electronic","value":"1573-2592"}],"subject":[],"published":{"date-parts":[[2020,6,25]]},"assertion":[{"value":"20 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}